Thyroid hormones are essential for maintaining a pregnancy and optimal fetal neurological development. Pregnancy places additional demands on the thyroid axis and around 5% of women who have their thyroid function checked during gestation will have borderline low thyroid function (subclinical hypothyroidism or isolated hypothyroxinemia) identified. These borderline low thyroid states are associated with adverse obstetric and offspring outcomes. Whilst it is well established that overt hypothyroidism requires treatment with levothyroxine, it is less clear whether there is any benefit of treating borderline low thyroid states. This review summarizes the potential indications for treatment of subclinical hypothyroidism and isolated hypothyroxinemia.
Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy / P.N. Taylor, I. Muller, M. Nana, I. Velasco, J.H. Lazarus. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1521-690X. - 34:4(2020 Jul). [10.1016/j.beem.2020.101436]
Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy
I. MullerCo-primo
;
2020
Abstract
Thyroid hormones are essential for maintaining a pregnancy and optimal fetal neurological development. Pregnancy places additional demands on the thyroid axis and around 5% of women who have their thyroid function checked during gestation will have borderline low thyroid function (subclinical hypothyroidism or isolated hypothyroxinemia) identified. These borderline low thyroid states are associated with adverse obstetric and offspring outcomes. Whilst it is well established that overt hypothyroidism requires treatment with levothyroxine, it is less clear whether there is any benefit of treating borderline low thyroid states. This review summarizes the potential indications for treatment of subclinical hypothyroidism and isolated hypothyroxinemia.File | Dimensione | Formato | |
---|---|---|---|
2020_Provisional_Taylor&Muller_Best Practice & Research Clinical Endocrinology & Metabolism.pdf
Open Access dal 02/07/2021
Descrizione: Articolo principale
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
966.95 kB
Formato
Adobe PDF
|
966.95 kB | Adobe PDF | Visualizza/Apri |
1-s2.0-S1521690X20300634-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
457.33 kB
Formato
Adobe PDF
|
457.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.